Veracyte (VCYT) Operating Income (2016 - 2025)
Historic Operating Income for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $22.9 million.
- Veracyte's Operating Income rose 9094.62% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 20516.99%. This contributed to the annual value of $16.1 million for FY2024, which is 11881.46% up from last year.
- Per Veracyte's latest filing, its Operating Income stood at $22.9 million for Q3 2025, which was up 9094.62% from -$5.3 million recorded in Q2 2025.
- Veracyte's 5-year Operating Income high stood at $22.9 million for Q3 2025, and its period low was -$45.4 million during Q1 2021.
- Moreover, its 5-year median value for Operating Income was -$8.1 million (2023), whereas its average is -$9.1 million.
- Per our database at Business Quant, Veracyte's Operating Income plummeted by 55511.07% in 2023 and then soared by 16237.11% in 2025.
- Over the past 5 years, Veracyte's Operating Income (Quarter) stood at -$12.3 million in 2021, then soared by 56.05% to -$5.4 million in 2022, then crashed by 555.11% to -$35.5 million in 2023, then surged by 111.76% to $4.2 million in 2024, then skyrocketed by 449.6% to $22.9 million in 2025.
- Its Operating Income was $22.9 million in Q3 2025, compared to -$5.3 million in Q2 2025 and $2.9 million in Q1 2025.